Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome.

The Mediterranean diet, featuring sourdough bread, shows promise in managing metabolic syndrome. This study explored the effects of two sourdough breads, with differing fermentation times but similar nutritional profiles, on inflammation, satiety, and gut microbiota composition in adults with metabo...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 16; no. 15; pp. 2380 - 2396
Autores principales: Pérez-Vega, Karla Alejandra, Sanllorente, Albert, Zomeño, María-Dolores, Quindós, Ana, Muñoz-Martínez, Júlia, Malcampo, Mireia, Aldea-Perona, Ana, Hernáez, Álvaro, Lluansí, Aleix, Llirós, Marc, Elias, Isidre, Elias-Masiques, Núria, Aldeguer, Xavier, Muñoz, Daniel, Gaixas, Sònia, Blanchart, Gemma, Schröder, Helmut, Hernando-Redondo, Javier, Carrón, Nerea, González-Torres, Pedro
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: MDPI Aug2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178948068&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178948068
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: Aug2024
      vid: 16
      iid: 15
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        178948068
        178948068
        178948068
        10.3390/nu16152380
        178948068
      ppf: 2380
      ppct: 16
      formats:
      tig:
        atl: Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome.
      aug:
        au:
          Pérez-Vega, Karla Alejandra
          Sanllorente, Albert
          Zomeño, María-Dolores
          Quindós, Ana
          Muñoz-Martínez, Júlia
          Malcampo, Mireia
          Aldea-Perona, Ana
          Hernáez, Álvaro
          Lluansí, Aleix
          Llirós, Marc
          Elias, Isidre
          Elias-Masiques, Núria
          Aldeguer, Xavier
          Muñoz, Daniel
          Gaixas, Sònia
          Blanchart, Gemma
          Schröder, Helmut
          Hernando-Redondo, Javier
          Carrón, Nerea
          González-Torres, Pedro
        affil: Hospital del Mar Research Institute, 08003 Barcelona, Spain
      sug:
        subj:
          Bread Therapeutic Use
          Fermentation
          Mediterranean Diet
          Metabolic Syndrome X Diet Therapy
          Time
          Human
          Funding Source
          Male
          Female
          Adult
          Middle Age
          Aged
          Randomized Controlled Trials
          Random Assignment
          Double-Blind Studies
          Sex Factors
          Inflammation
          Gut Microbiota
          Biological Markers
          Descriptive Statistics
          Plasminogen Activators
          Confidence Intervals
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: The Mediterranean diet, featuring sourdough bread, shows promise in managing metabolic syndrome. This study explored the effects of two sourdough breads, with differing fermentation times but similar nutritional profiles, on inflammation, satiety, and gut microbiota composition in adults with metabolic syndrome. In a double-blind clinical trial, participants were randomized to consume either Elias Boulanger® long-fermentation (48 h) sourdough bread (EBLong) or Elias Boulanger® short-fermentation (2 h) sourdough bread (EBShort) over a two-month period. We assessed clinical parameters, inflammatory biomarkers, satiety-related hormones, and the richness and abundance of gut microbiota at baseline and follow-up. The participants included 31 individuals (mean age, 67, 51.6% female). EBShort was associated with reduced levels of soluble intercellular adhesion molecule (sICAM), and all participants, regardless of the intervention, exhibited a decrease in sICAM and diastolic pressure from baseline (p < 0.017). At follow-up, plasminogen activator inhibitor-1 (PAI-1) levels were lower in EBShort (−744 pg/mL; 95%CI: −282 to −1210 pg/mL) compared to EBLong. No differences in microbiota richness or abundance were observed. EBShort bread was effective in reducing some inflammation markers. The consumption of sourdough bread may offer potential benefits in reducing inflammation markers in individuals with metabolic syndrome; however, longer fermentation times did not show additional benefits.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N